Treatment Interruption Decisions
Treatment Interruption Decisions is a clinical decision-making process in cardio-oncology that involves the temporary cessation or modification of cancer therapy due to cardiovascular toxicity, distinguished by its reliance on multidisciplinary risk stratification to balance oncologic efficacy and cardiovascular safety.
152
Publications
7.3K
Citations
1.1K
Authors
523
Institutions
Publications per year
2017–2026
44
152
Allen L. Gifford, Jill E. Bormann, Martha J. Shively et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2000 · 468 citations
1–5 of 152
1.1K
5
h-index
5
h-index
5
h-index
5
h-index
3
h-index
1–5 of 1.1K
523
University of North Carolina at Chapel Hill
Chapel Hill, United States
8 h-index
23 publications
2.1K citations
Inserm
Paris, France
7 h-index
48 publications
6.3K citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
6 h-index
20 publications
496 citations

Sorbonne Université
Paris, France
5 h-index
45 publications
6.2K citations
Harvard University
Cambridge, United States
5 h-index
9 publications
399 citations

Monash University
Melbourne, Australia
4 h-index
6 publications
120 citations
Assistance Publique – Hôpitaux de Paris
Paris, France
4 h-index
53 publications
7K citations
University of California, San Francisco
San Francisco, United States
4 h-index
12 publications
1.3K citations
1–8 of 523
Repository · 7 publications · 179 citations
7
h-index
5 publications · 207 citations
5
h-index
5 publications · 328 citations
5
h-index
5 publications · 846 citations
5
h-index
5 publications · 98 citations
5
h-index
1–5